So excited to finally share the latest from our group just published in @CellCellPress describing a next-generation trivalent COVID-19 vaccine that is designed to protect against all variants, and is delivered mucosally 1/n
This was a huge @McMasterU team effort, co-led with my incredibly talented colleagues, Dr. Zhou Xing and Dr. Brian Lichty. This vaccine is now in Phase I clinical trial, led by @inhaled_cov_vax 2/n
